Clinical characteristics of hepatocellular carcinomain elderly patients

Oncology Letters

Volumn 2, Issue 5, 2011, Pages 851-854

  Honda, Takuya ^a   Miyaaki, Hisamitsu ^a   Ichikawa, Tatsuki ^a   Taura, Naota ^a   Miuma, Satoshi ^a   Shibata, Hidetaka ^a   Isomoto, Hajime ^a   Takeshima, Fuminao ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Aging; Hepatocellular carcinoma; Non viral hepatocellular carcinoma

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY;

ADULT; AGED; AGING; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; SEX DIFFERENCE; TRANSARTERIAL CHEMOEMBOLIZATION;

EID: 79960327993     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.359     Document Type: Article

References (22)

1. Bosch FX, Ribes J, Diaz M and Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004
2. El-Serag HB and Mason AC: Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160: 3227-3230, 2000.
3. Kiyosawa K, Umemura T and Ichijo T, et al: Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127: S17-S26, 2004.
4. Taura N, Hamasaki K, Nakao K, et al: Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan. Oncol Rep 16: 837-843, 2006.
5. Kiyosawa K and Tanaka E: Characteristics of hepatocellular carcinoma in Japan. Oncology 62 (Suppl 1): 5-7, 2002.
6. Ng IO, Ng MM, Lai EC and Fan ST: Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 61: 134-137, 1996.
7. Lam CM, Chan AO, Ho P, et al: Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening. Aliment Pharmacol Ther 19: 771-777, 2004.
8. Falkson G, Cnaan A, Schutt AJ, Ryan LM and Falkson HC: Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 48: 7314-7318, 1988.
9. Ohishi W, Kitamoto M, Aikata H, et al: Impact of aging on the development of hepatocellular carcinoma in patients with hepatitis C virus infection in Japan. Scand J Gastroenterol 38: 894-900, 2003.
10. Hamada H, Yatsuhashi H, Yano K, et al: Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer 95: 331-339, 2002.
11. Chen CJ, Yang HI, Su J, et al: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. Jama 295: 65-73, 2006.
12. Chen CL, Yang HI, Yang WS, et al: Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135: 111-121, 2008.
13. Aikata H, Takaishi H, Kawakami Y, et al: Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 256: 578-582, 2000.
14. Isokawa O, Suda T, Aoyagi Y, et al: Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis. Hepatology 30: 408-412, 1999.
15. Yu J, Ni M, Xu J, et al: Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2: 29, 2002.
16. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ and Kang GH: Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163: 1371-1378, 2003.
17. Yang B, Guo M, Herman JG and Clark DP: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163: 1101-1107, 2003.
18. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231, 2005.
19. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540, 1994.
20. Huja N, Li Q, Mohan AL, Baylin SB and Issa JP: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58: 5489-5494, 1998.
21. Hashimoto E, Yatsuji S, Tobari M, et al: Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44 (Suppl 19): 89-95, 2009.
22. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF and Zein NN: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51: 1972-1978, 2010.